Try our mobile app

FDA Approves Pfizer's Supplemental New Drug Application for CIBINQO® (abrocitinib)

Published: 2023-02-10 17:09:00 ET
<<<  go to PFE company page

Label expansion for CIBINQO provides new systemic oral option for adolescents (12 to